The FDA approval of Zavzpret, which Pfizer announced in March 2023, is good news for people living with migraine, as it becomes an important option to help combat this disease.
/PRNewswire/ A new white paper from the Clinical Neurological Society of America explains how misconceptions about the FDA s Accelerated Drug Approval.
/PRNewswire/ Uncontrollable crying and laughing are the common symptoms of pseudobulbar affect, a prevalent yet overlooked neurological disorder that s the.